v3.26.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating activities:    
Net loss $ (8,529,263) $ (2,069,642)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 23,460 3,503
Amortization of ROU asset 15,566  
Change in fair value of SAFE liability 3,493,431 829,700
Share-based compensation expense 194,743  
Changes in operating assets and liabilities:    
Unbilled revenue 12,342 (12,342)
Prepaid expenses and other current assets (65,953) (49,956)
Other assets (106,935)  
Accounts payable 222,258 983
Accrued expenses and other liabilities (49,843) 203,628
Grant advance 144,000 48,000
Deferred revenue 23,617  
Operating lease liability 226  
Net cash used in operating activities (4,622,351) (1,046,126)
Investing activities:    
Purchase of property and equipment (246,993) (8,956)
Cash used in investing activities (246,993) (8,956)
Financing activities:    
Proceeds from issuance of SAFE liability 30,000 3,010,300
Proceeds from sale of convertible preferred stock and common stock warrants 12,125,830  
Payment of financing costs (77,739) 1,213
Cash provided by (used in) financing activities 12,078,091 3,011,513
Effect of exchange rates on cash and cash equivalents (6,267) (167)
Net increase (decrease) in cash and cash equivalents 7,202,480 1,956,264
Cash and cash equivalents at the beginning of the period 2,081,086 124,822
Cash and cash equivalents at the end of the period 9,283,566 $ 2,081,086
Supplemental non-cash investing and financing activities:    
Right-of-use assets obtained in exchange for operating lease obligations 146,750  
Deferred offering costs in accounts payable and accrued expenses 461,000  
Financing costs in accrued expenses 66,000  
Issuance of preferred stock upon conversion of SAFEs $ 7,488,431